Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children
Andrew D.J. Pearson(Pearson (United Kingdom)), Gilles Vassal(Université Paris-Saclay), Patrick A. Brown(Haemonetics (United States)), Giovanni Lesa(European Medicines Agency), Aundrietta D. Duncan(Io Therapeutics (United States)), Kimberly Stegmaier(Broad Institute), Scott A. Armstrong(Courant Institute of Mathematical Sciences), Michael J. Kelly(Binghamton University), Amy Barone(United States Food and Drug Administration), Michael L. Meyers(Eastern Cooperative Oncology Group), Joe McDonough(Andrew McDonough B+ Foundation), Ira Jacobs(University of Toronto), Franca Ligas(European Medicines Agency), Gregory H. Reaman(National Cancer Institute), Delphine Heenen(Anticancer Fund), Tilmann Taube(Boehringer Ingelheim (Germany)), Brian Gadbaw(Novartis (United States)), Miguel N. Rivera(University of North Texas), Susan Weiner, Malcolm A. Smith(National Cancer Institute), Elizabeth Fox(Children's National), Adrian M. Senderowicz, Mark W. Kieran(Children Cancer Hospital), Martha Donoghue(Center for Drug Evaluation and Research), Peter C. Adamson(University College London), Dominik Karres(European Medicines Agency), Daniel D. De Carvalho(University Health Network), Nada Jabado(McGill University), Donna Ludwinski(Solving Kids' Cancer), Koen Norga(Vlaams Instituut voor Biotechnologie), Maureen M. Hattersley(AstraZeneca (United States)), Lynley V. Marshall(Royal Marsden Hospital), Zariana Nikolova(Bristol-Myers Squibb (Switzerland)), Peter Ho(Epizyme (United States)), Christian Baumann(GlaxoSmithKline (United States)), Franck Bourdeaut(Institut Curie), Samuel C. Blackman, Victoria Buenger(Coalition Against Childhood Cancer)
Cited by 25
Related Papers
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
|Science|2006|5.5k
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
|Acta Neuropathologica|2012|1k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|914